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Bifidobacterium is an important, occasionally dominant, genus of the human intestinal microbiota whose presence in the human gastrointestinal tract (GIT) has been associated with several health benefits (12, 17) . Merging health-promoting activities and technological properties, B. animalis subsp. lactis (referred as B. lactis here) is one of the most common probiotic species in North America and Europe (3) . Because of its wide probiotic usage, different studies have been recently carried out with the attempt to better comprehend the molecular mechanisms involved in the bacteria-host interaction process (3, 11) . In this scenario, the capacity of this microorganism to intervene with the host plasmin(ogen) system has been recently regarded as a possible actor in the interplay with human enterocytes (11, 28) . However, the role of the human plasminogen (Plg) system in the biology of the bifidobacteria-host interaction process is still to be determined. The 92-kDa Plg is the monomeric pro-enzyme of the serine protease plasmin. Plg comprises an N-terminal 8-kDa preactivation peptide, five consecutive disulfide-bounded kringle domains (65 kDa) that mediate the binding to lysine-containing protein receptors, and a serine protease domain (25 kDa).
Although it is produced mainly by hepatocytes, other tissue sources of Plg have been identified, including the intestine (41). Plg is immobilized onto lysine-containing cell surface protein receptors such as fibrin as well as components of the extracellular matrix. Plg activation is a process tightly regulated by the balance between Plg activators (PA), such as urokinase (uPA) and tissue type (tPA) activators, and their specific inhibitors PAI-1/2. Involved in fibrinolysis, enhancement of cell migration and damages of tissue barriers, the Plg system has a key role in several human physiological and pathological processes (27) .
We previously reported the capability of B. lactis to bind human plasmin(ogen) (8) . Plg binding to the bifidobacterial cell surface is mediated by five cell wall protein receptors: DnaK, glutamine synthetase, enolase, bile salt hydrolase and phosphoglycerate mutase. According to Candela et al. (7) , in the presence of Plg and host PAs, B. lactis acquires a surface-bound Plg-derived proteolytic activity effective in the degradation of host physiological substrates. This modality of interaction with the components of the host Plg system resembles the one characteristic of several enteropathogens, such as Salmonella enterica, Listeria monocytogenes and Escherichia coli (16, 25, 29, 30, 32, 36) . Differently from Bifidobacterium, the role of Plg in bacterial pathogenicity has been determined and the bacterial capacity to intervene with the host Plg system has been traditionally considered as a paradigm of pathogenicity (5, 16, 25, 29, 30, 32, 35) . Facilitating the bacterial transmigration through epithelial monolayers, for pathogens the acquisition of a Plg-dependent surface-associated plasmin activity is necessary for dissemination in the host tissues. This process has been defined as bacterial metastasis in analogy to the role of Plg in tumor cell invasion (10, 31) .
Originally isolated from fermented milk (19) and commonly found in the gut of healthy adults and infants (38) , it is beyond any doubt that B. lactis possesses a mutualistic nature and its capacity to intervene with the host Plg system must serve a different purpose than the bacterial metastasis (7).
Consequently, even if B. lactis and pathogens show the same modality of interaction with the components of the host Plg system, the outcome of Plg-binding activity in the biology of interaction with the host must be different and the comprehension of its significance in the bifidobacterial ecology is needed. Here we studied the role of the human Plg system in the early interaction process between B. lactis BI07 and the human enterocyte line HT29 (26) . Moreover, since gastrointestinal inflammatory processes involve unbalances of the components of the host Plg system (14, 20, 23) , we investigated the impact of the pro-inflammatory cytokine TNF- on the dynamics of the Plgmediated B. lactis BI07-HT29 cell early interaction. TNF-was selected since this cytokine has been reported to play a central role in intestinal inflammation (18, 40) . (2) . Twenty-four h before each assay, the cell medium was changed with Interaction Medium (IM) (DMEM, 25 mM HEPES, 1 g/l glucose (Gibco), 1% FCS); when necessary, 2 ng/ml human recombinant TNF-α (Thermo Scientific) was added to induce a pro-inflammatory response (22) . For each experimental condition six independent replica experiments were performed. According to our data, the anti-human Plg pre-treatment resulted in a slight, but not significant (P > 0.05), decrease of the bifidobacterial adhesion to the enterocyte surface (-16%). These data indicated that the endogenously produced Plg of HT29 cells exerted only a minimal contribution to the B. lactis BI07-HT29 cell adhesion process. Consequently, in order to investigate the role of human Plg in the B. lactis BI07-enterocyte interaction process, bacterial cells were pre-incubated with human Plg (Sigma), as reported by Attali et al. (2) , and then subjected to a conventional HT29 cell adhesion assay (9) . Thirty-min pre-incubation at 37°C with 100 µg/ml human Plg significantly enhanced B.
Role of human
lactis BI07 adhesion to HT29 cells (+225%; P < 0.001) ( Table 1 Antibodies against B. lactis BI07 were generated in Balb/C mice according to standard protocols.
Microscopic analysis of the whole HT29 cell layer revealed no bacterial internalization by the HT29 enterocyte cell line in any of the tested conditions (Fig. 1A) . For comparison and as a control, the internalization of Salmonella enterica serovar Typhimurium by HT29 cells was determined using a gentamicin protection assay (13) . S. Typhimurium, provided by A. Essig (Dept. of Medical Microbiology, University of Ulm, Germany) was cultured as reported by Candela et al. (9) . In Even if the modality of interaction between B. lactis and the components of the host Plg system resembles the one described for several pathogens (16, 25, 29, 30, 32, 36) , our data demonstrated that the consequences of this interaction with respect to host colonization are different. In fact, for both B. lactis and pathogenic bacteria, cell-bound Plg enhances bacterial adhesion to the host epithelium (2, 24) , but in the presence of host PAs the phenotype of interaction with the host becomes totally different. Differently from pathogens, in B. lactis the acquisition of a surfaceassociated plasmin activity does not result in pericellular invasion, but rather supports the bacterial migration to the luminal compartment. Thus, common to symbionts and pathogens (1, 15) , the bacterial capacity to intervene with the host Plg system cannot be viewed as a determinant of pathogenicity by itself. Otherwise, it could be regarded as an ancestral mechanism of bacteria-host interaction evolved prior to the radiation of pathogens from commensals (6, 21) . Acting in concert with other virulence attributes (2, 21) , only in pathogens the capacity to intervene with the host Plg system becomes a fundamental prerequisite for host invasion (37) . (Table 1) . Moreover, after the TNFpre-incubation of HT29 layers, Plg pre-treated and Plg + uPA pre-treated B. lactis BI07 cells exhibited comparable adhesion values ( Table 1 ). The addition of aprotinin effectively restored the Plg-dependent B. lactis BI07 adhesion to TNF- stimulated HT29 layers for both Plg and Plg + uPA pre-treated B. lactis BI07 cells (Table 1 ). Analogously to the data obtained with non-inflamed HT29 cells, no bacterial internalization (Fig. 1B) and transmigration (data not shown) were detected when TNF- stimulated HT29 cells were incubated with Plg, Plg + uPA pre-treated and untreated B. lactis BI07 cells. Taken together these data indicated that, by enhancing the enterocyte capacity to activate Plg, a TNF-α-mediated inflammatory response can modulate the dynamics of the Plgmediated early interaction between B. lactis and human enterocytes, lowering the bacterial adhesion to the enterocyte surface and favoring the migration to the luminal compartment. Confirming this hypothesis, in a conventional plasmin activity assay (2, 7) we demonstrated that the TNF-α pretreatment increased by two-fold the HT29 cell capacity to activate Plg (P < 0.001).
Impact of TNF- on the
Our data suggest that B. lactis BI07 shows a different phenotype of interaction with the host Plg system depending on the inflammatory status of the host GIT epithelium. While in a non-inflamed GIT epithelium Plg enhances B. lactis adhesion, inflammation would result in the activation of bacterial bound Plg and mediate the migration of the microorganisms to the luminal compartment.
We hypothesize that this particular dynamic of interaction between B. lactis and the components of the host Plg system could be of some relevance in the bifidobacterial microecology in the human GIT. In non-inflamed regions of the human GIT, which represent the suitable ecological niche for B. lactis, the microorganism can take advantage of the host Plg for the adhesion to the mucosal surface. On the other hand, in inflamed tissue sites B. lactis would acquire a surface-associated plasmin activity that, facilitating the bacterial migration to the luminal compartment, could function as a bacterial escape mechanism to circumvent the host inflammatory response. Unable to face inflammation (34) , B. lactis may thus utilize the host Plg system to sense and escape intestinal inflammation, abandoning inflamed gastrointestinal sites in favor of non-inflamed ones. Our in vitro model of interaction could explain, at least in part, the observed decrease of the relative abundance of Bifidobacterium in IBD subjects (33, 39) .
Conclusions.
Investigating the role of Plg in the bifidobacterial biology in the human GIT, our experimental work represents a step forward in the comprehension of the factors that play a role in the dynamics of Bifidobacterium-host interaction in the human GIT. However, our in vitro data need to be confirmed by in vivo studies specifically designed to prove the role of the host Plg system in the inflammation-dependent bifidobacterial decrease in the human GIT. The achievement of this goal will allow a better understanding of the biology of this health-promoting microbiota component in the human GIT. 
